Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Ocugen Inc
(NQ:
OCGN
)
1.460
+0.030 (+2.10%)
Streaming Delayed Price
Updated: 12:49 PM EDT, Jun 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Ocugen Inc
< Previous
1
2
...
15
16
17
18
19
20
21
22
Next >
How Risky Is Ocugen After Its Recent Setback?
July 02, 2021
The U.S. vaccine market has slipped farther out of reach.
Via
The Motley Fool
Topics
Cannabis
Exposures
Cannabis
Better Short-Squeeze Stock: Clover Health or Ocugen?
July 02, 2021
Both have the necessary ingredients for explosive short-squeeze returns.
Via
The Motley Fool
Why Ocugen Shares Are Slipping Today
July 01, 2021
It could be due to the aftereffects of being included in a major stock index.
Via
The Motley Fool
Sell Ocugen Stock Before the Other Shoe Finally Drops
June 30, 2021
The bad news with Covaxin hasn't sunk in yet with OCGN stock investors, so get out while the stock still remains elevated.
Via
InvestorPlace
Exposures
COVID-19
What's Going On With Ocugen (OCGN) Stock Today?
June 30, 2021
Ocugen Inc (NASDAQ: OCGN) shares are trading 1.6% higher in the pre-market session on Wednesday amid high social media interest. The company's shares had closed nearly 2%...
Via
Benzinga
What's Next For Ocugen Stock As It Bounces Off Support?
June 22, 2021
Ocugen Inc. (NASDAQ:OCGN) shares are trading lower Tuesday...
Via
Benzinga
If Ocugen Stock Is Worth $8, I’ll Eat My Hat
June 29, 2021
OCGN stock at $8.35 looks ridiculously overvalued given the change in course
Via
InvestorPlace
Exposures
COVID-19
Ocugen Stock Is A Bust After Covaxin’s Emergency Use Rejection
June 29, 2021
OCGN stock is of no value to investors now that federal regulators closed the door on its Covid-19 vaccine commercialization efforts.
Via
InvestorPlace
Exposures
COVID-19
Product Safety
Is It Too Late to Buy Ocugen Stock?
June 29, 2021
The company has found a partner to manufacture its COVID-19 vaccine -- but will it be all for naught?
Via
The Motley Fool
Exposures
COVID-19
Get Rid of Ocugen Stock While You Can as the Bad News Piles Up
June 29, 2021
After OCGN stock rallied due to factors that were not based on fundamentals, investors should sell the shares.
Via
InvestorPlace
Exposures
COVID-19
Why Ocugen Climbed 8% Higher Today
June 24, 2021
The company will join a rarefied club starting early next week.
Via
The Motley Fool
3 Obscenely Overpriced Stocks I Wouldn't Buy Even if the Market Crashes
June 22, 2021
A lower price won't address these other risks.
Via
The Motley Fool
If You Invested $10,000 in Ocugen in December, This Is How Much You Would Have Today
June 20, 2021
Now the question is: Can your investment grow from here?
Via
The Motley Fool
Exposures
COVID-19
2 Stocks That Are Running Circles Around Bitcoin This Year
June 17, 2021
Can they keep outpacing the popular cryptocurrency?
Via
The Motley Fool
It’s Time to Admit Defeat and Dump Ocugen Stock as a Covid Play
June 16, 2021
After the FDA rejected Covaxin, Ocugen has almost no chance of generating profits from the shot. OCGN stock is a great short.
Via
InvestorPlace
Exposures
Product Safety
24 Stocks Moving in Wednday's Pre-Market Session
June 16, 2021
Gainers Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB) rose 43.6% to $2.93 in pre-market trading after a 13G filing from Ra Capital showed a 7.5% stake in the company. Greenland...
Via
Benzinga
Avoid These 3 Overvalued Reddit Stocks
June 16, 2021
Reddit stocks Tilray, Inc., Clover Health Investments, Corp., and Ocugen, Inc., which are currently trading at high valuations, are examples of Reddit stocks that we think could retreat in the...
Via
Talk Markets
Novavax COVID-19 Vaccine Could Become Available In India By September, Says Partner
June 16, 2021
Novavax Inc (NASDAQ: NVAX) COVID-19 vaccine, marketed as "Covovax," could see a launch in India as early as September, Moneycontrol reported on Wednesday...
Via
Benzinga
Exposures
COVID-19
OCGN Stock: Ocugen Fans Should Be Cheering This COVAXIN News
June 15, 2021
OCGN stock saw a glimmer of hope today. Where the company took a hit last week in deserting EUA, it is gaining today with a new partnership.
Via
InvestorPlace
Exposures
COVID-19
Product Safety
Why Ocugen Stock Rallied Today
June 15, 2021
The biotech is bolstering its production capabilities for an experimental coronavirus vaccine.
Via
The Motley Fool
Exposures
COVID-19
34 Stocks Moving In Tuesday's Mid-Day Session
June 15, 2021
Gainers HMG/Courtland Properties, Inc. (NYSE: HMG) shares surged 133% to $27.80. Alfi, Inc. (NASDAQ: ALF) shares jumped 82.1% to $6.21 after the company inked an agreement with...
Via
Benzinga
Ocugen Stock Jumps After Recruiting Jubilant HollisterStier As Manufacturing Partner For COVID-19 Vaccine Candidate
June 15, 2021
Ocugen Inc (NASDAQ: OCGN) has selected Jubilant HollisterStier of Spokane, Washington as its manufacturing partner for COVID-19 vaccine candidate, Covaxin for the...
Via
Benzinga
Exposures
COVID-19
Thinking About Buying Stock Or Options In Royal Caribbean Group, Ocugen Or Spirit Airlines?
June 15, 2021
Royal Caribbean Cruises Ltd (NYSE:RCL) Tuesday announced that...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 15, 2021
Gainers Clearside Biomedical (NASDAQ:CLSD) stock increased by 50.99% to $4.56 during Tuesday's pre-market session. The market value of their outstanding shares is at $...
Via
Benzinga
Ocugen Stock Crashes: What Should Investors Do Now?
June 15, 2021
Here are three steps to take.
Via
The Motley Fool
Exposures
COVID-19
Product Safety
Will This News Stop Ocugen Shares in Their Tracks?
June 14, 2021
This high flyer is still up more than 260% this year.
Via
The Motley Fool
Exposures
COVID-19
Where Will Ocugen Be in 1 Year?
June 12, 2021
This biotech underdog's dream of selling a coronavirus vaccine in the U.S. just went up in smoke.
Via
The Motley Fool
Exposures
COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For June 11, 2021
June 11, 2021
Upgrades Barclays upgraded the previous rating for Ventas Inc (NYSE:VTR) from Equal-Weight to Overweight. In the first quarter, Ventas showed an EPS of $0.72, compared to...
Via
Benzinga
10 Biggest Price Target Changes For Friday
June 11, 2021
Barclays lowered Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) price target from $302 to $285. Vertex Pharmaceuticals shares fell 13.3% to $187.88 in pre-market trading....
Via
Benzinga
66 Biggest Movers From Yesterday
June 11, 2021
Gainers Orphazyme A/S (NASDAQ: ORPH) shares jumped 302.3% to close at $21.00 on Thursday. Shares of the biopharmaceutical firm touched an intraday high of $77.77, running up 1,...
Via
Benzinga
< Previous
1
2
...
15
16
17
18
19
20
21
22
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.